Werner Olipitz
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
- Cancer Immunotherapy and Biomarkers 2
-
- Acute Myeloid Leukemia Research 5
- Co-authors
- Bevin P. Engelward (5 shared papers)Heinz Sill (6 shared papers)Orsolya Király (1 shared paper)Guanyu Gong (1 shared paper)Sureshkumar Muthupalani (1 shared paper)Albert Wölfler (2 shared papers)Eduard Schulz (2 shared papers)Armin Zebisch (2 shared papers)
- Journals
- International Journal of Cancer (2 papers)Journal of Neuroimmunology (1 paper)British Journal of Haematology (1 paper)Genes Chromosomes and Cancer (1 paper)Acta Haematologica (1 paper)
- Partner nations
- United StatesAustriaGreece
In The Last Decade
Werner Olipitz
14 papers receiving 507 citations
Peers
Comparison fields: 5 of 77
- Hematology 134
- Cancer Research 95
- Oncology 130
- Genetics 48
- Immunology 95
Countries citing papers authored by Werner Olipitz
This map shows the geographic impact of Werner Olipitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Olipitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Olipitz more than expected).
Fields of papers citing papers by Werner Olipitz
This network shows the impact of papers produced by Werner Olipitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Olipitz. The network helps show where Werner Olipitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Olipitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 127 | |
| 2 | 2010 | 94 | |
| 3 | 2009 | 80 | |
| 4 | 2012 | 77 | |
| 5 | 2006 | 34 | |
| 6 | 2009 | 29 | |
| 7 | 2002 | 28 | |
| 8 | 2008 | 13 | |
| 9 | 2006 | 12 | |
| 10 | 2004 | 12 | |
| 11 | 1999 | 10 | |
| 12 | 2004 | 3 | |
| 13 | 2000 | 3 | |
| 14 | 2010 | 1 |
About Werner Olipitz
Werner Olipitz is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Cancer Research, having authored 14 papers that have together received 523 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), DNA Repair Mechanisms (5 papers), PARP inhibition in cancer therapy (3 papers), Cancer Genomics and Diagnostics (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Genetic factors in colorectal cancer (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Hematology (134 citations), Cancer Research (95 citations), Oncology (130 citations), Genetics (48 citations) and Immunology (95 citations). Werner Olipitz has collaborated with scholars based in United States, Austria and Greece. Frequent co-authors include Bevin P. Engelward, Heinz Sill, Orsolya Király, Guanyu Gong, Sureshkumar Muthupalani, Albert Wölfler, Eduard Schulz, Armin Zebisch, Carrie A. Hendricks and Tatiana Levkovich. Their work appears in journals such as International Journal of Cancer, Journal of Neuroimmunology, British Journal of Haematology, Genes Chromosomes and Cancer and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.